Table 2.
Patient | Seizure onset age | Age at test | Pyridoxine dose | ALDH7A1 mutations (NM_001182.4) | Development | |
---|---|---|---|---|---|---|
Language | Motor | |||||
1 | 3 months | 4y3 months | 180 mg bid (18.0 mg/kg/d) | c.1061A >G; Deletion of exon 8–13 | Moderate | Normal |
2 | 3.5 months | 8y7 months | 100 mg bid (7.0 mg/kg/d) | c.1553G > C; c.1061A > G | Normal | Normal |
3 | 23 days | 3y4 months | 30 mg tid (5.0 mg/kg/d) | c.1279G > C; c.1279G > C | Mild | Normal |
4 | 6 months | 4y5 months | 60 mg tid (8.9 mg/kg/d) | c.1547A > G; c.212C > T | Normal | Normal |
5 | 2 days | 3 years | 50 mg tid (9.1 mg/kg/d) | c.1008+1G > A; c.796C > T | Mild | Normal |
6 | 1 days | 5y6 months | 60 mg tid (8.1 mg/kg/d) | IVS17-1_7delCCACTAG+c.1566_1567delTA; c.871+5G > A | Moderate | Normal |
7 | 1y1 months | 5y4 months | 60 mg tid (8.2 mg/kg/d) | c.1279G > C; c.986G > A | Mild | Normal |
8 | 8 days | 6y1 months | 60 mg tid (7.7 mg/kg/d) | c.965 C > T; c.952 G > C | Normal | Normal |
9 | 2 months | 5y8 months | 60 mg tid (7.9 mg/kg/d) | c.410G > A; c.1008+1G > A | Normal | Mild |
10 | 1 days | 4y5 months | 50 mg tid (7.5 mg/kg/d) | c.1415+1G > T; c.871+5G > A | Mild | Normal |
11 | 1 days | 3y10 months | 40 mg tid (6.8 mg/kg/d) | c.1531G > A; c.1008+1G > A | Severe | Normal |
12 | 5 months | 5y3 months | 80 mg tid (10.9 mg/kg/d) | c.1061A > G; c.1008+1G > A | Mild | Normal |
13 | 1 months | 4y9 months | 30 mg tid (4.3 mg/kg/d) | c.1547A > G; c.1061A > G | Mild | Mild |
14 | 1.5 months | 1y4 months | 60 mg tid (12.9 mg/kg/d) | c.1547A > G; c.1547A > G | Normal | Normal |
15 | 8 days | 2y6 months | 15 mg bid (1.8 mg/kg/d) | c.1547A > G; c.1072C > T | Mild | Normal |